0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Urea Cycle Disorder Agent Market Research Report 2026
Published Date: 2026-01-30
|
Report Code: QYRE-Auto-28D18196
Home | Market Reports | Health| Pharmacy
Global Urea Cycle Disorder Agent Market Research Report 2024
BUY CHAPTERS

Global Urea Cycle Disorder Agent Market Research Report 2026

Code: QYRE-Auto-28D18196
Report
2026-01-30
Pages:104
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Urea Cycle Disorder Agent Market

The global Urea Cycle Disorder Agent market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
Urea Cycle Disorder (UCD) Agent refers to a therapeutic agent specifically designed to treat or manage conditions associated with the urea cycle. The urea cycle is a critical biochemical pathway in humans and other animals that converts ammonia, a toxic byproduct of protein metabolism, into urea, which is then excreted through the urine. Disorders of the urea cycle, collectively known as Urea Cycle Disorders (UCDs), are inherited metabolic conditions that impair this process, leading to the accumulation of ammonia in the bloodstream, which can be life-threatening.
The North American market for Urea Cycle Disorder Agent is projected to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % over 2026–2032.
The Asia-Pacific market for Urea Cycle Disorder Agent is projected to rise from US$ million in 2025 to US$ million by 2032, at a CAGR of % over 2026–2032.
The global market for Urea Cycle Disorder Agent in Hospital is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 to 2032.
Major global companies of Urea Cycle Disorder Agent include Horizon Pharma, Lee's Pharmaceutical, Medunik, Sigmapharm Laboratories, Amgen, Acer Therapeutics, Immedica, etc. In 2025, the world's top three vendors accounted for approximately % of revenue.
This report delivers a comprehensive overview of the global Urea Cycle Disorder Agent market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Urea Cycle Disorder Agent. The Urea Cycle Disorder Agent market size, estimates, and forecasts are provided in terms of revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.
The report segments the global Urea Cycle Disorder Agent market comprehensively. Regional market sizes by Type, by Application, , and by player are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist Urea Cycle Disorder Agent manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
Market Segmentation

Scope of Urea Cycle Disorder Agent Market Report

Report Metric Details
Report Name Urea Cycle Disorder Agent Market
Segment by Type
  • Glycerol Phenylbutyrate
  • Sodium Phenylbutyrate
Segment by Application
  • Hospital
  • Pharmacy
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Horizon Pharma, Lee's Pharmaceutical, Medunik, Sigmapharm Laboratories, Amgen, Acer Therapeutics, Immedica
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
  • Chapter 2: Summarizes global and regional market size and outlines market dynamics and recent developments, including key drivers, restraints, challenges and risks for industry participants, and relevant policy analysis.
  • Chapter 3: Provides a detailed view of the competitive landscape for Urea Cycle Disorder Agent companies, covering revenue share, development plans, and mergers and acquisitions.
  • Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify blue-ocean opportunities.
  • Chapter 5: Analyzes segments by Application, detailing the size and growth potential of each downstream segment to help readers identify blue-ocean opportunities.
  • Chapter 6–10: Regional deep dives (North America, Europe, Asia Pacific, Latin America, Middle East & Africa) broken down by country. Each chapter quantifies market size and growth potential by region and key countries, and outlines market development, outlook, addressable space, and capacity.
  • Chapter 11: Profiles key players, presenting essential information on leading companies, including product/ service offerings, revenue, gross margin, product introductions/portfolios, recent developments, etc.
  • Chapter 12: Key findings and conclusions of the report.

FAQ for this report

Who are the main players in the Urea Cycle Disorder Agent Market report?

Ans: The main players in the Urea Cycle Disorder Agent Market are Horizon Pharma, Lee's Pharmaceutical, Medunik, Sigmapharm Laboratories, Amgen, Acer Therapeutics, Immedica

What are the Application segmentation covered in the Urea Cycle Disorder Agent Market report?

Ans: The Applications covered in the Urea Cycle Disorder Agent Market report are Hospital, Pharmacy

What are the Type segmentation covered in the Urea Cycle Disorder Agent Market report?

Ans: The Types covered in the Urea Cycle Disorder Agent Market report are Glycerol Phenylbutyrate, Sodium Phenylbutyrate

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Urea Cycle Disorder Agent Market Size Growth Rate by Type: 2021 vs 2025 vs 2032
1.2.2 Glycerol Phenylbutyrate
1.2.3 Sodium Phenylbutyrate
1.3 Market by Application
1.3.1 Global Urea Cycle Disorder Agent Market Growth by Application: 2021 vs 2025 vs 2032
1.3.2 Hospital
1.3.3 Pharmacy
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Urea Cycle Disorder Agent Market Perspective (2021–2032)
2.2 Global Urea Cycle Disorder Agent Growth Trends by Region
2.2.1 Global Urea Cycle Disorder Agent Market Size by Region: 2021 vs 2025 vs 2032
2.2.2 Urea Cycle Disorder Agent Historic Market Size by Region (2021–2026)
2.2.3 Urea Cycle Disorder Agent Forecasted Market Size by Region (2027–2032)
2.3 Urea Cycle Disorder Agent Market Dynamics
2.3.1 Urea Cycle Disorder Agent Industry Trends
2.3.2 Urea Cycle Disorder Agent Market Drivers
2.3.3 Urea Cycle Disorder Agent Market Challenges
2.3.4 Urea Cycle Disorder Agent Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Urea Cycle Disorder Agent Players by Revenue
3.1.1 Global Top Urea Cycle Disorder Agent Players by Revenue (2021–2026)
3.1.2 Global Urea Cycle Disorder Agent Revenue Market Share by Players (2021–2026)
3.2 Global Top Urea Cycle Disorder Agent Players Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
3.3 Global Key Players Ranking by Urea Cycle Disorder Agent Revenue
3.4 Global Urea Cycle Disorder Agent Market Concentration Ratio
3.4.1 Global Urea Cycle Disorder Agent Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Urea Cycle Disorder Agent Revenue in 2025
3.5 Global Key Players of Urea Cycle Disorder Agent Head Offices and Areas Served
3.6 Global Key Players of Urea Cycle Disorder Agent, Products and Applications
3.7 Global Key Players of Urea Cycle Disorder Agent, Date of General Availability (GA)
3.8 Mergers and Acquisitions, Expansion Plans
4 Urea Cycle Disorder Agent Breakdown Data by Type
4.1 Global Urea Cycle Disorder Agent Historic Market Size by Type (2021–2026)
4.2 Global Urea Cycle Disorder Agent Forecasted Market Size by Type (2027–2032)
5 Urea Cycle Disorder Agent Breakdown Data by Application
5.1 Global Urea Cycle Disorder Agent Historic Market Size by Application (2021–2026)
5.2 Global Urea Cycle Disorder Agent Forecasted Market Size by Application (2027–2032)
6 North America
6.1 North America Urea Cycle Disorder Agent Market Size (2021–2032)
6.2 North America Urea Cycle Disorder Agent Market Growth Rate by Country: 2021 vs 2025 vs 2032
6.3 North America Urea Cycle Disorder Agent Market Size by Country (2021–2026)
6.4 North America Urea Cycle Disorder Agent Market Size by Country (2027–2032)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Urea Cycle Disorder Agent Market Size (2021–2032)
7.2 Europe Urea Cycle Disorder Agent Market Growth Rate by Country: 2021 vs 2025 vs 2032
7.3 Europe Urea Cycle Disorder Agent Market Size by Country (2021–2026)
7.4 Europe Urea Cycle Disorder Agent Market Size by Country (2027–2032)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Ireland
8 Asia-Pacific
8.1 Asia-Pacific Urea Cycle Disorder Agent Market Size (2021–2032)
8.2 Asia-Pacific Urea Cycle Disorder Agent Market Growth Rate by Region: 2021 vs 2025 vs 2032
8.3 Asia-Pacific Urea Cycle Disorder Agent Market Size by Region (2021–2026)
8.4 Asia-Pacific Urea Cycle Disorder Agent Market Size by Region (2027–2032)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia & New Zealand
9 Latin America
9.1 Latin America Urea Cycle Disorder Agent Market Size (2021–2032)
9.2 Latin America Urea Cycle Disorder Agent Market Growth Rate by Country: 2021 vs 2025 vs 2032
9.3 Latin America Urea Cycle Disorder Agent Market Size by Country (2021–2026)
9.4 Latin America Urea Cycle Disorder Agent Market Size by Country (2027–2032)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Urea Cycle Disorder Agent Market Size (2021–2032)
10.2 Middle East & Africa Urea Cycle Disorder Agent Market Growth Rate by Country: 2021 vs 2025 vs 2032
10.3 Middle East & Africa Urea Cycle Disorder Agent Market Size by Country (2021–2026)
10.4 Middle East & Africa Urea Cycle Disorder Agent Market Size by Country (2027–2032)
10.5 Israel
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Horizon Pharma
11.1.1 Horizon Pharma Company Details
11.1.2 Horizon Pharma Business Overview
11.1.3 Horizon Pharma Urea Cycle Disorder Agent Introduction
11.1.4 Horizon Pharma Revenue in Urea Cycle Disorder Agent Business (2021–2026)
11.1.5 Horizon Pharma Recent Development
11.2 Lee's Pharmaceutical
11.2.1 Lee's Pharmaceutical Company Details
11.2.2 Lee's Pharmaceutical Business Overview
11.2.3 Lee's Pharmaceutical Urea Cycle Disorder Agent Introduction
11.2.4 Lee's Pharmaceutical Revenue in Urea Cycle Disorder Agent Business (2021–2026)
11.2.5 Lee's Pharmaceutical Recent Development
11.3 Medunik
11.3.1 Medunik Company Details
11.3.2 Medunik Business Overview
11.3.3 Medunik Urea Cycle Disorder Agent Introduction
11.3.4 Medunik Revenue in Urea Cycle Disorder Agent Business (2021–2026)
11.3.5 Medunik Recent Development
11.4 Sigmapharm Laboratories
11.4.1 Sigmapharm Laboratories Company Details
11.4.2 Sigmapharm Laboratories Business Overview
11.4.3 Sigmapharm Laboratories Urea Cycle Disorder Agent Introduction
11.4.4 Sigmapharm Laboratories Revenue in Urea Cycle Disorder Agent Business (2021–2026)
11.4.5 Sigmapharm Laboratories Recent Development
11.5 Amgen
11.5.1 Amgen Company Details
11.5.2 Amgen Business Overview
11.5.3 Amgen Urea Cycle Disorder Agent Introduction
11.5.4 Amgen Revenue in Urea Cycle Disorder Agent Business (2021–2026)
11.5.5 Amgen Recent Development
11.6 Acer Therapeutics
11.6.1 Acer Therapeutics Company Details
11.6.2 Acer Therapeutics Business Overview
11.6.3 Acer Therapeutics Urea Cycle Disorder Agent Introduction
11.6.4 Acer Therapeutics Revenue in Urea Cycle Disorder Agent Business (2021–2026)
11.6.5 Acer Therapeutics Recent Development
11.7 Immedica
11.7.1 Immedica Company Details
11.7.2 Immedica Business Overview
11.7.3 Immedica Urea Cycle Disorder Agent Introduction
11.7.4 Immedica Revenue in Urea Cycle Disorder Agent Business (2021–2026)
11.7.5 Immedica Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
 Table 1. Global Urea Cycle Disorder Agent Market Size Growth Rate by Type (US$ Million): 2021 vs 2025 vs 2032
 Table 2. Key Players of Glycerol Phenylbutyrate
 Table 3. Key Players of Sodium Phenylbutyrate
 Table 4. Global Urea Cycle Disorder Agent Market Size Growth by Application (US$ Million): 2021 vs 2025 vs 2032
 Table 5. Global Urea Cycle Disorder Agent Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
 Table 6. Global Urea Cycle Disorder Agent Market Size by Region (US$ Million), 2021–2026
 Table 7. Global Urea Cycle Disorder Agent Market Share by Region (2021–2026)
 Table 8. Global Urea Cycle Disorder Agent Forecasted Market Size by Region (US$ Million), 2027–2032
 Table 9. Global Urea Cycle Disorder Agent Market Share by Region (2027–2032)
 Table 10. Urea Cycle Disorder Agent Market Trends
 Table 11. Urea Cycle Disorder Agent Market Drivers
 Table 12. Urea Cycle Disorder Agent Market Challenges
 Table 13. Urea Cycle Disorder Agent Market Restraints
 Table 14. Global Urea Cycle Disorder Agent Revenue by Players (US$ Million), 2021–2026
 Table 15. Global Urea Cycle Disorder Agent Market Share by Players (2021–2026)
 Table 16. Global Top Urea Cycle Disorder Agent Players by Tier (Tier 1, Tier 2, and Tier 3), based on Urea Cycle Disorder Agent Revenue, 2025
 Table 17. Ranking of Global Top Urea Cycle Disorder Agent Companies by Revenue (US$ Million) in 2025
 Table 18. Global 5 Largest Players Market Share by Urea Cycle Disorder Agent Revenue (CR5 and HHI), 2021–2026
 Table 19. Global Key Players of Urea Cycle Disorder Agent, Headquarters and Area Served
 Table 20. Global Key Players of Urea Cycle Disorder Agent, Products and Applications
 Table 21. Global Key Players of Urea Cycle Disorder Agent, Date of General Availability (GA)
 Table 22. Mergers and Acquisitions, Expansion Plans
 Table 23. Global Urea Cycle Disorder Agent Market Size by Type (US$ Million), 2021–2026
 Table 24. Global Urea Cycle Disorder Agent Revenue Market Share by Type (2021–2026)
 Table 25. Global Urea Cycle Disorder Agent Forecasted Market Size by Type (US$ Million), 2027–2032
 Table 26. Global Urea Cycle Disorder Agent Revenue Market Share by Type (2027–2032)
 Table 27. Global Urea Cycle Disorder Agent Market Size by Application (US$ Million), 2021–2026
 Table 28. Global Urea Cycle Disorder Agent Revenue Market Share by Application (2021–2026)
 Table 29. Global Urea Cycle Disorder Agent Forecasted Market Size by Application (US$ Million), 2027–2032
 Table 30. Global Urea Cycle Disorder Agent Revenue Market Share by Application (2027–2032)
 Table 31. North America Urea Cycle Disorder Agent Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
 Table 32. North America Urea Cycle Disorder Agent Market Size by Country (US$ Million), 2021–2026
 Table 33. North America Urea Cycle Disorder Agent Market Size by Country (US$ Million), 2027–2032
 Table 34. Europe Urea Cycle Disorder Agent Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
 Table 35. Europe Urea Cycle Disorder Agent Market Size by Country (US$ Million), 2021–2026
 Table 36. Europe Urea Cycle Disorder Agent Market Size by Country (US$ Million), 2027–2032
 Table 37. Asia-Pacific Urea Cycle Disorder Agent Market Size Growth Rate by Region (US$ Million): 2021 vs 2025 vs 2032
 Table 38. Asia-Pacific Urea Cycle Disorder Agent Market Size by Region (US$ Million), 2021–2026
 Table 39. Asia-Pacific Urea Cycle Disorder Agent Market Size by Region (US$ Million), 2027–2032
 Table 40. Latin America Urea Cycle Disorder Agent Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
 Table 41. Latin America Urea Cycle Disorder Agent Market Size by Country (US$ Million), 2021–2026
 Table 42. Latin America Urea Cycle Disorder Agent Market Size by Country (US$ Million), 2027–2032
 Table 43. Middle East & Africa Urea Cycle Disorder Agent Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
 Table 44. Middle East & Africa Urea Cycle Disorder Agent Market Size by Country (US$ Million), 2021–2026
 Table 45. Middle East & Africa Urea Cycle Disorder Agent Market Size by Country (US$ Million), 2027–2032
 Table 46. Horizon Pharma Company Details
 Table 47. Horizon Pharma Business Overview
 Table 48. Horizon Pharma Urea Cycle Disorder Agent Product
 Table 49. Horizon Pharma Revenue in Urea Cycle Disorder Agent Business (US$ Million), 2021–2026
 Table 50. Horizon Pharma Recent Development
 Table 51. Lee's Pharmaceutical Company Details
 Table 52. Lee's Pharmaceutical Business Overview
 Table 53. Lee's Pharmaceutical Urea Cycle Disorder Agent Product
 Table 54. Lee's Pharmaceutical Revenue in Urea Cycle Disorder Agent Business (US$ Million), 2021–2026
 Table 55. Lee's Pharmaceutical Recent Development
 Table 56. Medunik Company Details
 Table 57. Medunik Business Overview
 Table 58. Medunik Urea Cycle Disorder Agent Product
 Table 59. Medunik Revenue in Urea Cycle Disorder Agent Business (US$ Million), 2021–2026
 Table 60. Medunik Recent Development
 Table 61. Sigmapharm Laboratories Company Details
 Table 62. Sigmapharm Laboratories Business Overview
 Table 63. Sigmapharm Laboratories Urea Cycle Disorder Agent Product
 Table 64. Sigmapharm Laboratories Revenue in Urea Cycle Disorder Agent Business (US$ Million), 2021–2026
 Table 65. Sigmapharm Laboratories Recent Development
 Table 66. Amgen Company Details
 Table 67. Amgen Business Overview
 Table 68. Amgen Urea Cycle Disorder Agent Product
 Table 69. Amgen Revenue in Urea Cycle Disorder Agent Business (US$ Million), 2021–2026
 Table 70. Amgen Recent Development
 Table 71. Acer Therapeutics Company Details
 Table 72. Acer Therapeutics Business Overview
 Table 73. Acer Therapeutics Urea Cycle Disorder Agent Product
 Table 74. Acer Therapeutics Revenue in Urea Cycle Disorder Agent Business (US$ Million), 2021–2026
 Table 75. Acer Therapeutics Recent Development
 Table 76. Immedica Company Details
 Table 77. Immedica Business Overview
 Table 78. Immedica Urea Cycle Disorder Agent Product
 Table 79. Immedica Revenue in Urea Cycle Disorder Agent Business (US$ Million), 2021–2026
 Table 80. Immedica Recent Development
 Table 81. Research Programs/Design for This Report
 Table 82. Key Data Information from Secondary Sources
 Table 83. Key Data Information from Primary Sources
 Table 84. Authors List of This Report


List of Figures
 Figure 1. Urea Cycle Disorder Agent Picture
 Figure 2. Global Urea Cycle Disorder Agent Market Size Comparison by Type (US$ Million), 2021–2032
 Figure 3. Global Urea Cycle Disorder Agent Market Share by Type: 2025 vs 2032
 Figure 4. Glycerol Phenylbutyrate Features
 Figure 5. Sodium Phenylbutyrate Features
 Figure 6. Global Urea Cycle Disorder Agent Market Size by Application (US$ Million), 2021–2032
 Figure 7. Global Urea Cycle Disorder Agent Market Share by Application: 2025 vs 2032
 Figure 8. Hospital Case Studies
 Figure 9. Pharmacy Case Studies
 Figure 10. Urea Cycle Disorder Agent Report Years Considered
 Figure 11. Global Urea Cycle Disorder Agent Market Size (US$ Million), Year-over-Year: 2021–2032
 Figure 12. Global Urea Cycle Disorder Agent Market Size, (US$ Million), 2021 vs 2025 vs 2032
 Figure 13. Global Urea Cycle Disorder Agent Market Share by Region: 2025 vs 2032
 Figure 14. Global Urea Cycle Disorder Agent Market Share by Players in 2025
 Figure 15. Global Urea Cycle Disorder Agent Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
 Figure 16. The Top 10 and 5 Players Market Share by Urea Cycle Disorder Agent Revenue in 2025
 Figure 17. North America Urea Cycle Disorder Agent Market Size YoY Growth (US$ Million), 2021–2032
 Figure 18. North America Urea Cycle Disorder Agent Market Share by Country (2021–2032)
 Figure 19. United States Urea Cycle Disorder Agent Market Size YoY Growth (US$ Million), 2021–2032
 Figure 20. Canada Urea Cycle Disorder Agent Market Size YoY Growth (US$ Million), 2021–2032
 Figure 21. Europe Urea Cycle Disorder Agent Market Size YoY Growth (US$ Million), 2021–2032
 Figure 22. Europe Urea Cycle Disorder Agent Market Share by Country (2021–2032)
 Figure 23. Germany Urea Cycle Disorder Agent Market Size YoY Growth (US$ Million), 2021–2032
 Figure 24. France Urea Cycle Disorder Agent Market Size YoY Growth (US$ Million), 2021–2032
 Figure 25. U.K. Urea Cycle Disorder Agent Market Size YoY Growth (US$ Million), 2021–2032
 Figure 26. Italy Urea Cycle Disorder Agent Market Size YoY Growth (US$ Million), 2021–2032
 Figure 27. Russia Urea Cycle Disorder Agent Market Size YoY Growth (US$ Million), 2021–2032
 Figure 28. Ireland Urea Cycle Disorder Agent Market Size YoY Growth (US$ Million), 2021–2032
 Figure 29. Asia-Pacific Urea Cycle Disorder Agent Market Size YoY Growth (US$ Million), 2021–2032
 Figure 30. Asia-Pacific Urea Cycle Disorder Agent Market Share by Region (2021–2032)
 Figure 31. China Urea Cycle Disorder Agent Market Size YoY Growth (US$ Million), 2021–2032
 Figure 32. Japan Urea Cycle Disorder Agent Market Size YoY Growth (US$ Million), 2021–2032
 Figure 33. South Korea Urea Cycle Disorder Agent Market Size YoY Growth (US$ Million), 2021–2032
 Figure 34. Southeast Asia Urea Cycle Disorder Agent Market Size YoY Growth (US$ Million), 2021–2032
 Figure 35. India Urea Cycle Disorder Agent Market Size YoY Growth (US$ Million), 2021–2032
 Figure 36. Australia & New Zealand Urea Cycle Disorder Agent Market Size YoY Growth (US$ Million), 2021–2032
 Figure 37. Latin America Urea Cycle Disorder Agent Market Size YoY Growth (US$ Million), 2021–2032
 Figure 38. Latin America Urea Cycle Disorder Agent Market Share by Country (2021–2032)
 Figure 39. Mexico Urea Cycle Disorder Agent Market Size YoY Growth (US$ Million), 2021–2032
 Figure 40. Brazil Urea Cycle Disorder Agent Market Size YoY Growth (US$ Million), 2021–2032
 Figure 41. Middle East & Africa Urea Cycle Disorder Agent Market Size YoY Growth (US$ Million), 2021–2032
 Figure 42. Middle East & Africa Urea Cycle Disorder Agent Market Share by Country (2021–2032)
 Figure 43. Israel Urea Cycle Disorder Agent Market Size YoY Growth (US$ Million), 2021–2032
 Figure 44. Saudi Arabia Urea Cycle Disorder Agent Market Size YoY Growth (US$ Million), 2021–2032
 Figure 45. UAE Urea Cycle Disorder Agent Market Size YoY Growth (US$ Million), 2021–2032
 Figure 46. Horizon Pharma Revenue Growth Rate in Urea Cycle Disorder Agent Business (2021–2026)
 Figure 47. Lee's Pharmaceutical Revenue Growth Rate in Urea Cycle Disorder Agent Business (2021–2026)
 Figure 48. Medunik Revenue Growth Rate in Urea Cycle Disorder Agent Business (2021–2026)
 Figure 49. Sigmapharm Laboratories Revenue Growth Rate in Urea Cycle Disorder Agent Business (2021–2026)
 Figure 50. Amgen Revenue Growth Rate in Urea Cycle Disorder Agent Business (2021–2026)
 Figure 51. Acer Therapeutics Revenue Growth Rate in Urea Cycle Disorder Agent Business (2021–2026)
 Figure 52. Immedica Revenue Growth Rate in Urea Cycle Disorder Agent Business (2021–2026)
 Figure 53. Bottom-up and Top-down Approaches for This Report
 Figure 54. Data Triangulation
 Figure 55. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic

$2900

Single User License
Electronic

$4350

Multi User License
Electronic

$5800

Enterprise License
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Accenture

SIMILAR REPORTS